June 13, 2022 | Pharma industry, Pharmaceuticals, clinical trials, patient recruitment, webinar
Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to market. But recruitment is also one of the biggest challenges for trials. More than four in five studies fail to meet their recruitment deadlines, which can result in costly delays for sponsors and puts sites under increasing pressure. This issue has been exacerbated by the COVID-19 pandemic; with many trials initially put on hold and now restarting, sponsors want to make up for lost time by accelerating patient recruitment and retention. However, clinical trial staff are struggling to clear this enrollment backlog.This webinar will explore some of the key challenges to patient recruitment particularly since COVID-19, and highlight how a ‘boots on the ground’ approach via Clinical Enrollment Managers (CEMs) can help supercharge patient recruitment and retention strategy by:Understanding the local environment and culture in each country where sites are basedWorking with sites and developing strategies to help them overcome recruitment barriersSustained community engagement within key patient populations, including those who are traditionally underrepresented in trials
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Kate Shaw comments on the latest news about AstraZeneca and Merck’s decision to hold planned investments in the UK
Boosting screening & enrollment rates in a global oncology trial
Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,…
Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which…
So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.
Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden House Hospice Care as its UK charity partner for 2025/26. It continues…
Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.
Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!
🎉 Cheers to 15 years of patient recruitment and retention innovation and impact at Innovative Trials! 🎉 From 2010 to 2025, we’ve been on an incredible journey of growth, impact,…
John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth
